Rock Springs Capital Management LP Q4 2016 Filing
Filed February 14, 2017
Portfolio Value
$1.5B
Holdings
133
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (133 positions)
| Stock | Value |
|---|---|
—TESARO INC | $82.5M |
ALXNALEXION PHARMACEUTICALS INC | $56.9M |
—AETNA INC NEW | $54.7M |
MRKMERCK & CO INC | $44.2M |
—GW PHARMACEUTICALS PLC | $39.8M |
ACHCACADIA HEALTHCARE COMPANY IN | $38.3M |
—ALLERGAN PLC | $34.9M |
—RADIUS HEALTH INC | $34.6M |
CICIGNA CORPORATION | $33.6M |
WCGEURWELLCARE HEALTH PLANS INC | $32.1M |
—SPARK THERAPEUTICS INC | $31.2M |
ISRGINTUITIVE SURGICAL INC | $30.4M |
ACRSACLARIS THERAPEUTICS INC | $29.9M |
ARDXARDELYX INC | $28.4M |
CELGCELGENE CORP | $28.1M |
UNHUNITEDHEALTH GROUP INC | $26.4M |
BMYBRISTOL MYERS SQUIBB CO | $26.3M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $24.9M |
—ADVANCED ACCELERATOR APPLIC | $24.9M |
LLYLILLY ELI & CO | $23.9M |
—MEDICINES CO | $23.7M |
—SHIRE PLC | $23.4M |
PCRXPACIRA PHARMACEUTICALS INC | $23.0M |
GILDGILEAD SCIENCES INC | $19.8M |
TBPHTHERAVANCE BIOPHARMA INC | $19.1M |
PENPENUMBRA INC | $18.9M |
INCYINCYTE CORP | $16.9M |
PRAHPRA HEALTH SCIENCES INC | $16.5M |
NBIXNEUROCRINE BIOSCIENCES INC | $15.9M |
AMRNAMARIN CORP PLC | $15.4M |
—WRIGHT MED GROUP N V | $15.3M |
PRTAPROTHENA CORP PLC | $15.2M |
AMGNAMGEN INC | $14.1M |
CHRSCOHERUS BIOSCIENCES INC | $13.6M |
JAZZJAZZ PHARMACEUTICALS PLC | $13.5M |
GLPGGALAPAGOS NV | $13.5M |
WTWWILLIS TOWERS WATSON PUB LTD | $13.5M |
BIIBBIOGEN INC | $13.3M |
WBAWALGREENS BOOTS ALLIANCE INC | $13.3M |
—RA PHARMACEUTICALS INC | $12.5M |
DHRDANAHER CORP DEL | $12.5M |
—PATHEON N V | $11.5M |
EWEDWARDS LIFESCIENCES CORP | $11.3M |
RAREULTRAGENYX PHARMACEUTICAL IN | $11.2M |
—DERMIRA INC | $11.0M |
—HEALTHSOUTH CORP | $10.9M |
HOLXHOLOGIC INC | $10.6M |
BMRNBIOMARIN PHARMACEUTICAL INC | $10.4M |
—THERAPEUTICSMD INC | $9.9M |
—RETROPHIN INC | $9.9M |
NVTA1EURINVITAE CORP | $9.5M |
—ENVISION HEALTHCARE CORP | $9.2M |
—AUDENTES THERAPEUTICS INC | $8.9M |
MRUSMERUS N V | $8.4M |
CLSDUSDCLEARSIDE BIOMEDICAL INC | $8.4M |
—FIVE PRIME THERAPEUTICS INC | $8.2M |
—PARATEK PHARMACEUTICALS INC | $8.1M |
ONCBEIGENE LTD | $8.0M |
REGNREGENERON PHARMACEUTICALS | $7.2M |
LGNDLIGAND PHARMACEUTICALS INC | $7.1M |
ALKSALKERMES PLC | $6.9M |
—EPIZYME INC | $6.9M |
—EGALET CORP | $6.8M |
—AVEXIS INC | $6.7M |
VRTXVERTEX PHARMACEUTICALS INC | $6.6M |
—ATHENAHEALTH INC | $6.6M |
ASNDASCENDIS PHARMA A S | $6.6M |
CRVSCORVUS PHARMACEUTICALS INC | $6.4M |
IM8NINSMED INC | $6.2M |
—RTI SURGICAL INC | $6.0M |
EXASEXACT SCIENCES CORP | $6.0M |
—AIMMUNE THERAPEUTICS INC | $6.0M |
—ACHILLION PHARMACEUTICALS IN | $5.7M |
—PROTEOSTASIS THERAPEUTICS IN | $5.5M |
—CHINA CORD BLOOD CORP | $5.4M |
SRPTSAREPTA THERAPEUTICS INC | $5.3M |
FGENEURFIBROGEN INC | $5.1M |
CLVSEURCLOVIS ONCOLOGY INC | $4.9M |
MEDPMEDPACE HLDGS INC | $4.9M |
ASMBASSEMBLY BIOSCIENCES INC | $4.7M |
—ADURO BIOTECH INC | $4.7M |
MGNXMACROGENICS INC | $4.6M |
—STERIS PLC | $4.4M |
CGENCOMPUGEN LTD | $4.2M |
—INTERSECT ENT INC | $4.2M |
—NOVADAQ TECHNOLOGIES INC | $3.9M |
—ALLERGAN PLC | $3.8M |
—ALDER BIOPHARMACEUTICALS INC | $3.8M |
AM6AMICUS THERAPEUTICS INC | $3.8M |
—JUNO THERAPEUTICS INC | $3.7M |
—MEDICINES CO | $3.6M |
INVAINNOVIVA INC | $3.6M |
—KITE PHARMA INC | $3.5M |
OTICEUROTONOMY INC | $3.3M |
—CARDIOME PHARMA CORP | $3.3M |
—NABRIVA THERAPEUTICS AG | $3.1M |
—CIDARA THERAPEUTICS INC | $3.1M |
—ARIAD PHARMACEUTICALS INC | $3.1M |
PBYIPUMA BIOTECHNOLOGY INC | $2.9M |
ITCIEURINTRA CELLULAR THERAPIES INC | $2.9M |
Page 1 of 2Next